JP:4503 Stock Latest News
Pre-EarningsIs ALPMF a Buy, Before Earnings?3M ago
Company AnnouncementsAstellas Pharma Cuts Director Slate After Outside Director Resigns5M ago
Company AnnouncementsAstellas Launches Five-Year CSP2026 Plan Targeting Pipeline-Led Record Revenues5M ago
Company AnnouncementsAstellas Extends Global Performance-Linked Stock Incentives for Executives5M ago
Company AnnouncementsAstellas Extends Performance-Linked Stock Incentive Plan for Directors in FY20265M ago
Company AnnouncementsAstellas Pharma Announces New Board Slate and Governance Changes for 20266M ago
Pre-EarningsIs ALPMF a Buy, Before Earnings?6M ago
Company AnnouncementsAstellas Highlights R&D Strategy While Flagging Market and Development Risks7M ago
Company AnnouncementsAstellas and HOVON Phase 3 AML Trial for Xospata Misses Survival Goal7M ago
Company AnnouncementsAstellas Flags Risks and Uncertainties Around Sustainability Plans and Pipeline8M ago
Company AnnouncementsAstellas Lifts FY2025 Outlook on Robust XTANDI and Mirabegron Demand9M ago
Pre-EarningsALPMF Upcoming Earnings Report: What to Expect?9M ago
Company AnnouncementsAstellas and Pfizer Unveil Breakthrough in Bladder Cancer Treatment10M ago
Company AnnouncementsAstellas Pharma Revises FY2025 Financial Forecasts Upward1y ago
Pre-EarningsAstellas Pharma (ALPMF) Q2 Earnings Cheat Sheet1y agoCompany AnnouncementsAstellas Pharma’s GLEAM Trial Falls Short of Primary Endpoint in Pancreatic Cancer Study1y ago
Company AnnouncementsAstellas Pharma’s IZERVAY Gains Conditional Approval in Japan for Geographic Atrophy1y ago

